Latest Publications
Information about recent research performed by FORWARD collaborators using FORWARD data.
Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic
The authors of this study, which was led by Kaleb Michaud, Ph.D., of the University of Nebraska Medical Center in Omaha, and Kristin Wipfler, Ph.D., of FORWARD, set out to understand how the COVID-19 pandemic has impacted the lives of RA patients in the United States.
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis
To examine the comparative effects of biologic disease-modifying antirheumatic drugs and tofacitinib against conventional synthetic DMARDs on incident cardiovascular disease in patients with rheumatoid arthritis.
Historical Publications
Information about past research performed by FORWARD collaborators using FORWARD data, organized by year.
The Journal of Rheumatology
Journal article
Health Technology Assessment
Journal article
Arthritis Care & Research
Journal article
Arthritis Care & Research
Journal article
2020 Annual European Congress of Rheumatology
Abstract
2020 Annual European Congress of Rheumatology
Abstract
2020 Annual European Congress of Rheumatology
Abstract
2020 Annual European Congress of Rheumatology
Oral Presentation
Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID‐19 Pandemic
ACR Open Rheumatology
Journal article
Arthritis care & research
Journal article
ACR open rheumatology
Journal article
ACR Open Rheumatology
Journal article
Seminars in Arthritis and Rheumatism
Journal article
Arthritis Care & Research
Journal article
Arthritis Care & Research
Journal article
The Journal of Rheumatology
Journal article
Annals of the rheumatic diseases
Journal article
Quality of life research
Journal article
Arthritis research & therapy
Journal article
Seminars in arthritis and rheumatism
Journal article
Arthritis Care & Research
Journal article
Clinical and experimental rheumatology
Journal article
ACR Open Rheumatology
Journal article
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
2019 ACR/ARP Annual Meeting
Abstract
ACR Open Rheumatology
Journal article
RMD Open
Journal article
2019 Annual European Congress of Rheumatology
Oral Presentation
2019 Annual European Congress of Rheumatology
Abstract
2019 Annual European Congress of Rheumatology
Abstract
2019 Annual European Congress of Rheumatology
Abstract
The Journal of rheumatology
Journal article
Scandinavian journal of pain
Journal article
ACR Open Rheumatology
Journal article
The Journal of Rheumatology
Journal article
Rheumatology
Journal article
Journal of managed care & specialty pharmacy
Journal article
Arthritis care & research
Journal article
Arthritis care & research
Journal article
International immunopharmacology
Journal article
2018 Annual European Congress of Rheumatology
Journal article
JMIR research protocols
Journal article
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 Annual European Congress of Rheumatology
Abstract
2018 Annual European Congress of Rheumatology
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
2018 ACR/ARHP Annual Meeting
Abstract
Lupus Science & Medicine
Journal article
2018 Annual European Congress of Rheumatology
Abstract
2018 Annual European Congress of Rheumatology
Abstract
2018 Annual European Congress of Rheumatology
Abstract
Arthritis & Rheumatology
Journal article
Annals of the rheumatic diseases
Journal article
Arthritis care & research
Journal article
Arthritis care & research
Journal article
Rheumatology
Journal article
Pharmacoepidemiology and Drug Safety
Journal article
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
2017 ACR/ARHP Annual Meeting
Abstract
Journal of Pharmaceutical Health Services Research
Journal article
2017 Annual European Congress of Rheumatology
Abstract
Arthritis & rheumatology
Journal article
Arthritis care & research
Journal article
Arthritis & Rheumatology
Journal article
Clinical and Experimental Rheumatology
Journal article
Arthritis care & research
Journal article
2016 ACR/ARHP Annual Meeting
Abstract
APHA 2016 Annual Meeting
Abstract
2016 International Society for Pharmacoeconomics and Outcomes Research Conference
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 ACR/ARHP Annual Meeting
Abstract
2016 Annual European Congress of Rheumatology
Abstract
2016 Annual European Congress of Rheumatology
Abstract
2016 Annual European Congress of Rheumatology
Abstract
Seminars in arthritis and rheumatism
Journal article
Arthritis care & research
Journal article
The journal of rheumatology
Journal article
Arthritis & Rheumatology
Journal article
RMD open
Journal article
Rheumatology
Journal article
Rheumatology
Journal article
2015 Annual European Congress of Rheumatology
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 ACR/ARHP Annual Meeting
Abstract
2015 Annual European Congress of Rheumatology
Abstract
2015 Annual European Congress of Rheumatology
Abstract
PLOS ONE
Journal article
The Journal of rheumatology
Journal article
Clinical and experimental rheumatology
Journal article
Arthritis care & research
Journal article
Medical Decision Making
Journal article
Arthritis care & research
Journal article
2014 ACR/ARHP Annual Meeting
Abstract
2014 Annual European Congress of Rheumatology
Journal article
2014 ACR/ARHP Annual Meeting
Abstract
2014 Annual European Congress of Rheumatology
Oral Presentation
QUALITY OF LIFE RESEARCH
Journal article
2014 ACR/ARHP Annual Meeting
Abstract
2014 ACR/ARHP Annual Meeting
Abstract
2014 ACR/ARHP Annual Meeting
Abstract
2014 ACR/ARHP Annual Meeting
Abstract
PLOS ONE
Journal article
Arthritis care & research
Journal article
Journal of psychosomatic research
Journal article
Arthritis care & research
Journal article
2014 ACR/AHRP Annual Scientific Meeting
Abstract
Lupus
Journal article
Rheumatology
Journal article
Journal of Bone and Mineral Research
Journal article
European Journal of Pain
Journal article
2013 ACR/ARHP Annual Meeting
Abstract
2013 Annual European Congress of Rheumatology
Abstract
2013 Annual European Congress of Rheumatology
Abstract
2013 ACR/ARHP Annual Meeting
Abstract
PharmacoEconomics & Outcomes News
Journal article
2013 ACR/ARHP Annual Meeting
Abstract
Arthritis care & research
Journal article
Nature Reviews Rheumatology
Journal article
Arthritis care & research
Journal article
2013 ACR/ARHP Annual Meeting
Abstract
2013 ACR/ARHP Annual Meeting
Abstract
Arthritis care & research
Journal article
Arthritis care & research
Journal article
The Journal of rheumatology
Journal article
The Journal of rheumatology
Journal article
Arthritis care & research
Journal article
Comparison of Discontinuation Rates by Biologic Since 1998 in US Patients with Rheumatoid Arthritis.
2012 ACR/ARHP Annual Meeting
Abstract
2012 ACR/ARHP Annual Meeting
Abstract
HEDS Discussion Paper
Working paper
Quality of Life Research
Abstract
2012 ACR/ARHP Annual Meeting
Abstract
2012 ACR/ARHP Annual Meeting
Abstract
Journal of Rheumatology
Journal article
PLoS One
Journal article
Clin Exp Rheumatol
Journal article
2012 ACR/ARHP Annual Meeting
Abstract
2012 ACR/ARHP Annual Meeting
Abstract
2012 Annual European Congress of Rheumatology
Abstract
Arthritis care & research
Journal article
Rheumatology
Journal article
Pain medicine
Journal article
Arthritis & Rheumatism
Journal article
Arthritis care & research
Journal article
Arthritis research & therapy 13 (5), R
Journal article
The Journal of rheumatology
Journal article
Arthritis & Rheumatism
Journal article
Arthritis and rheumatism
Journal article
2011 ACR/ARHP Annual Meeting
Abstract
2011 ACR/ARHP Annual Meeting
Abstract
Arthritis care & research
Journal article
2011 ACR/ARHP Annual Meeting
Abstract
2011 ACR/ARHP Annual Meeting
Abstract
2011 ACR/ARHP Annual Meeting
Abstract
2011 ACR/ARHP Annual Meeting
Abstract
2011 ACR/ARHP Annual Meeting
Abstract
The Journal of rheumatology
Journal article
The Journal of rheumatology
Journal article
PAIN
Journal article
Arthritis care & research
Journal article
Arthritis care and research (2010)
Journal article
Seminars in arthritis and rheumatism 40 (1), 2-14.
Book chapter
The Journal of rheumatology
Journal article
The Journal of rheumatology
Journal article
Arthritis research & therapy 12 (2), R
Journal article
The Journal of rheumatology
Journal article
Arthritis care & research
Journal article
Arthritis care & research
Journal article
The Journal of rheumatology
Journal article
2010 International Society for Pharmacoeconomics and Outcomes Research Conference
Abstract
2010 International Society for Pharmacoeconomics and Outcomes Research Conference
Abstract
2010 International Society for Pharmacoeconomics and Outcomes Research Conference
Abstract
2010 International Society for Pharmacoeconomics and Outcomes Research Conference
Abstract
Journal of Rheumatology
Journal article
Arthritis care & research
Journal article
Arthritis care & research
Journal article
Journal of International Medical Research
Journal article
Arthritis research & therapy 12 (2), R
Journal article
Investigative Ophthalmology & Visual Science
Journal article
Wolfe F, Petri M, Alarcon GS, Goldman J, Chakravarty EF, Katz RS, et al. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity. J Rheumatol. 2009 Jan;36(1):82-8. PubMed link
Bergman MJ, Shahouri SH, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, et al. Is Fatigue an Inflammatory Variable in Rheumatoid Arthritis (RA)? Analyses of Fatigue, Osteoarthritis, and Fibromyalgia. J Rheumatol. 2009;36:2788-94. PubMed link
Allaire S, Wolfe F, Niu J, LaValley MP, Zhang B, Reisine S. Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort. Arthritis & Rheumatism. 2009 Mar 15;61(3):321-8.
Wolfe F. Fibromyalgia wars. J Rheumatol. 2009 Apr;36(4):671-8.
Wolfe F. Fibromyalgianess. Arthritis & Rheumatism. 2009 Jun 15;61(6):715-6.
Wolfe F, Michaud K. Out of pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2009;61(11):1563-70.
Wolfe F, Michaud K. Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J Rheumatol. 2009 Apr;36(4):831-6.
Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis & Rheumatism. 2009 May 15;61(5):667-73.
Wolfe F, Michaud K. Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure. J Rheumatol. 2009 Jan;36(1):27-33.
Wolfe F, Boers M, Felson D, Michaud K, Wells GA. Remission in rheumatoid arthritis: physician and patient perspectives. J Rheumatol. 2009 May;36(5):930-3.
Finckh A, Bansback N, Marra CA, Anis AH, Michaud K, Lubin S, White M, Sizto S, Liang MH. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med. 2009;151(9):612. PubMed link
Pons-Estel B, Sanchez-Guerrero J, Romero-Diaz J, Inglesias A, Bonfa E, Shinjo SK, et al. Validation of the Spanish, Portuguese and French Versions of the Lupus Damage Index Questionnaire: Data from North and South America, Spain and Portugal. Lupus. 2009;18(12):1033-52.
Shaver TS, Anderson JD, Weidensaul DN, Shahouri SS, Busch RE, Mikuls TR, et al. The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol. 2008;35(6):1015-22. PubMed link
Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO, 3rd, Harris CL, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis & Rheumatism. 2008 Oct;58(10):3183-91.
Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM, Wolfe F. Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis. Arthritis & Rheumatism. 2008;58(4):939-46. PubMed link
Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study. Arthritis & Rheumatism. 2008;59(8):1090-6.
Allaire S, Wolfe F, Niu J, LaValley MP. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis & Rheumatism. 2008;59(4):474-80.
Vera-Llonch M, Massarotti E, Wolfe F, Shadick N, Westhovens R, Sofrygin O, et al. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate. Rheumatology (Oxford). 2008 Apr;47(4):535-41.
Vera-Llonch M, Massarotti E, Wolfe F, Shadick N, Westhovens R, Sofrygin O, et al. Cost-Effectiveness of Abatacept in Patients with Moderately to Severely Active Rheumatoid Arthritis and Inadequate Response to Tumor Necrosis Factor-alpha Antagonists. J Rheumatol. 2008.
Hoffman HM, Wolfe F, Belomestnov P, Mellis SJ. Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity. Curr Med Res Opin. 2008 Sep;24(9):2531-43.
Cannon GW, Pincus SH, Emkey RD, Denes A, Cohen SA, Wolfe F, et al. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989. Arthritis & Rheumatism. 2008 Feb;58(2 Suppl):S79-88.
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis & Rheumatism. 2008;58(1):26-35.
Allaire S, Wolfe F, Niu J, Zhang Y, Zhang B, LaValley M. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: The jury is still out. Arthritis & Rheumatism. 2008;59(8):1082-9.
Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, et al. Malignancies in the rheumatoid arthritis abatacept clinical development program: An epidemiological assessment. Ann Rheum Dis. 2008 Dec 3.
Wolfe F, Michaud K. Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis. J Rheumatol. 2008;35(6):1023-30.
Wolfe F, Michaud K. Proposed Metrics for the Determination of Rheumatoid Arthritis Outcome and Treatment Success and Failure. J Rheumatol. 2008 Dec 1.
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis & Rheumatism. 2008 Oct 15;59(10):1371-7.
Wolfe F, Michaud K. The challenges of determining RA disease activity and remission in clinical practice. NatClinPractRheumatol. 2008.
Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis & Rheumatism. 2008 Sep;58(9):2612-21.
Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis & Rheumatism. 2007;56(6):1745-53. PubMed link
Wolfe F, Michaud K. Assessment of Pain in Rheumatoid Arthritis: Minimal Clinically Significant Difference, Predictors, and the Effect of Anti-Tumor Necrosis Factor Therapy. J Rheumatol. 2007.
Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study. Arthritis & Rheumatism. 2007;56(9):2886-95.
Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. BestPractResClinRheumatol. 2007;21(5):885-906.
Caplan L, Wolfe F, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol. 2007;34(4):696-705. PubMed link
Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F. Influence of Nonclassical Cardiovascular Risk Factors on the Accuracy of Predicting Subclinical Atherosclerosis in Rheumatoid Arthritis. J Rheumatol. 2007;34(5):943-51.
Wolfe F, Rasker JJ, Boers M, Wells GA, Michaud K. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Arthritis & Rheumatism. 2007;57(6):935-42.
Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile JM, et al. Not all “quality-adjusted life years” are equal. J ClinEpidemiol. 2007;60(6):616-24.
Wolfe F, Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: Discordance between disease activity and patients’ treatment choices. Arthritis & Rheumatism. 2007;56(7):2135-42.
Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol. 2007;36(3):172-8. PubMed link
Michaud K, Wolfe F. The development of a rheumatic disease research comorbidity index for use in outpatients patients with RA, OA, SLE and fibromyalgia (FMS). Arthritis and Rheumatism (Suppl). 2007;56(9):S596.
Benito-Garcia E, Michaud K, Wolfe F. The Effect of Low-Dose Aspirin on the Decreased Risk of Development of Dyspepsia and Gastrointestinal Ulcers Associated to Cyclooxygenase-2 Selective Inhibitors. J Rheumatol. 2007.
Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON-YEARS of observation. Arthritis & Rheumatism. 2007;56(5):1433-9.
Wolfe F. The effective use of questionnaires in clinical practice. Arthritis & Rheumatism. 2007;57(5):705-6.
Garcia EB, Wolfe F. The potentials and challenges of patient registries. Acta ReumatolPort. 2007;32(4):313-5.
Wolfe F, Allaire S, Michaud K. The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol. 2007 Nov;34(11):2211-7.
Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis & Rheumatism. 2006;54(1):169-76.
Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. NEnglJ Med. 2006;354(8):795-808.
Wolfe F, Michaud K. Anemia and renal function in patients with rheumatoid arthritis. J Rheumatol. 2006;33(8):1516-22.
Wolfe F, Michaud K, Simon T. Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases? J Rheumatol. 2006;33(10):1952-6.
Wolfe F, Michaud K, Strand V. Dr. Wolfe, et al reply. J Rheumatol. 2006;33(2):435.
Allaire S, Wolfe F, Niu J, Baker N, Michaud K, LaValley M. Extent of occupational hand use among persons with rheumatoid arthritis. Arthritis & Rheumatism. 2006;55(2):294-9.
Garcia EB, Michaud K, Wolfe F. Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists. J Rheumatol. 2006;33(4):779-84.
Dewitt EM, Glick HA, Albert DA, Joffe MM, Wolfe F. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians’ prescribing behavior. ArchInternMed. 2006;166(1):57-63.
Finckh A, de PP, Katz JN, Neumann G, Lu Y, Wolfe F, et al. Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal study. Arthritis & Rheumatism. 2006;54(5):1444-50.
Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras. Trends towards milder disease in Rheumatoid Arthritis are attributable to improved therapy. AnnRheumDis. 2006.
Goligher EC, Duryea J, Liang MH, Wolfe F, Finckh A. Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year’s duration. Arthritis & Rheumatism. 2006;54(5):1440-3.
Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford). 2006;45(11):1370-5. PubMed link
Wolfe F, Michaud K, Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol. 2006;33(10):1942-51.
Michaud K, Wolfe F. The association of rheumatoid arthritis and its treatment with sinus disease. J Rheumatol. 2006;33(12):2412-5.
Wolfe F, Rasker JJ. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol. 2006;33(11):2291-9.
Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis & Rheumatism. 2006;54(2):628-34. PubMed link
Wolfe F, Katz RS, Michaud K. Jaw Pain: Its Prevalence and Meaning in Patients with Rheumatoid Arthritis, Osteoarthritis, and Fibromyalgia. J Rheumatol. 2005;32(12):2421-8.
Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of Putative Candidate-Gene Associations with Rheumatoid Arthritis in > 4,000 Samples from North America and Sweden: Association of Susceptibility with PTPN22, CTLA4, and PADI4. AmJ HumGenet. 2005;77(6):1044-60. PubMed link
Wolfe F, Michaud K. A brief introduction to the National Data Bank for Rheumatic Diseases. Clin ExpRheumatol. 2005;23(5):S168-S71.
Wolfe F, Michaud K, Pincus T. A Composite Disease Activity Scale for Clinical Practice, Observational Studies and Clinical Trials: The Patient Activity Scale (PAS/PAS-II). JRheumatol. 2005;32(12):2410-5.
Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32(6):1013-9.
Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis & Rheumatism. 2005;52(7):2015-25.
Wolfe F, Michaud K, Strand V. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol. 2005;32(4):583-9.
Wolfe F, Michaud K, Choi HK, Williams R. Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol. 2005;32(10):1875-83.
Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol. 2005;32(10):2016-24.
Pincus T, Wolfe F. Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients? J Rheumatol. 2005;32(4):575-7.
Wolfe F, Michaud K, Pincus T. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis. J Rheumatol. 2005;32(7):1261-6.
Pincus T, Yazici Y, Yazici H, Kavanaugh AF, Kremer JM, Wolfe F. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: Comment on the article by Smolen et al. Arthritis & Rheumatism. 2005;52(12):4044-5.
Ward RJ, Chris Buckland-Wright J, Wolfe F. Relationships between tibial rim alignment and joint space width measurement reproducibility in non-fluoroscopic radiographs of osteoarthritic knees. OsteoarthritisCartilage. 2005.
Mazzuca SA, Brandt KD, Schauwecker DS, Katz BP, Meyer JM, Lane KA, et al. Severity of joint pain and kellgren-lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis. J Rheumatol. 2005;32(8):1540-6.
Chakravarty EF, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol. 2005;32(11):2130-5. PubMed link
Caplan L, Russell AS, Wolfe F. Steroids for rheumatoid arthritis: the honeymoon revisited (once again). J Rheumatol. 2005;32(10):1863-5. PubMed link
Wolfe F, Michaud K, Pincus T, Furst D, Keystone E. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis & Rheumatism. 2005;52(12):3873-9.
Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005;6(2):129-33.
Wolfe F, Michaud K. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness. Rheumatology (Oxford). 2005;44 Suppl 4:iv18-iv22.
Wolfe F, Michaud K, Pincus T, Pangan AL, Kent j. Usefulness Of A Visual Analog Function Scale In Ra Clinical Trials: Increased Sensitivity Compared With Conventional Measures. ArthritisRheum. 2005;50.
Wolfe F. Why the HAQ-II can be an effective substitute for the HAQ. ClinExpRheumatol. 2005;23(5 Suppl 39):S29-S30.
Allaire S, Wolfe F, Niu J, LaValley M, Michaud K. Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis. Arthritis & Rheumatism. 2005;53(4):603-8.
Walker N, Michaud K, Wolfe F. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients. J Rheumatol. 2005;32(6):1006-12.
Wolfe F. A short history of data banking in the United States from 1974 to 2003. JRheumatolSuppl. 2004;69:41-5.
Wolfe F, Zhao S, Pettitt D. Blood Pressure Destabilization and Edema Among 8538 Users of Celecoxib, Rofecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs (NSAID) and Nonusers of NSAID Receiving Ordinary Clinical Care. JRheumatol. 2004;31(6):1143-51.
Fewell z, Hernan MA, Wolfe F, Tilling H, Choi HK, Sterne AC. Controlling for time-dependent confounding using marginal structural models. Stata Journal. 2004;4(4):402-20.
Wolfe F, Michaud K. Corticosteroids increase the risk of diabetes mellitus in RA and contribute to the risk of myocardial infarction and heart failure. AnnRheumDis. 2004;63:379.
Wolfe F, Michaud K. Data collection, maintenance, and analysis for rheumatic disease research. RheumDisClinNorth Am. 2004;30(4):753-68.
Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol. 2004;31(8):1621-9.
Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis & Rheumatism. 2004;50(10):3296-305.
Wolfe F, Michaud K, Pincus T. Do rheumatology cost-effectiveness analyses make sense? Rheumatology(Oxford). 2004;43(1):4-6.
Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. JRheumatol. 2004;31(10):1896-902.
Wolfe F. From the outside of Plato’s cave. Rheumatology(Oxford). 2004;43(1):112-3.
Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. AmJMed. 2004;116(5):305-11.
Stern R, Wolfe F. Infliximab dose and clinical status: results of 2 studies in 1642 patients with rheumatoid arthritis. JRheumatol. 2004;31(8):1538-45.
Wolfe F, Michaud K, Burke TA, Zhao SZ. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice. JRheumatol. 2004;31(2):355-8.
Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis & Rheumatism. 2004;50(6):1740-51.
Wolfe F, Caplan L, Michaud K. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model. JRheumatol. 2004;31(12):2317-9. PubMed link
Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. AnnRheumDis. 2004;63(8):931-9.
Wolfe F, Michaud K. Prednisone but not biologics or DMARDs is associated with increased risk of myocardial infarction in persons with RA. AnnRheumDis. 2004;63:69.
Wolfe F, Michaud K. Rates and risk factors for herpes zoster in patients with rheumatoid arthritis. AnnRheumDis. 2004;63:103.
Wolfe F. Rheumatology grand rounds at rush: patient self-report data are key to better patient care. J ClinRheumatol. 2004;10(6):347-9.
Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. JRheumatol. 2004;31(4):695-700.
Mazzuca SA, Brandt KD, Katz BP, Lane KA, Bradley JD, Heck LW, et al. Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug. Arthritis & Rheumatism. 2004;51(6):933-40.
Wolfe F, Michaud K, Kahler K, Omar M. The Short Arthritis Assessment Scale: a brief assessment questionnaire for rapid evaluation of arthritis severity in research and clinical practice. JRheumatol. 2004;31(12):2472-9.
Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis & Rheumatism. 2004;50(2):372-9.
Sharp JT, Wolfe F, Lassere M, Boers M, van der HD, Larsen A, et al. Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers. JRheumatol. 2004;31(6):1062-72.
Wolfe F, Michaud K, Dewitt EM. Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues. AnnRheumDis. 2004;63 Suppl 2:ii13-ii7.
Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis & Rheumatism. 2003;48(3):625-30.
Wolfe F, Michaud K, Choi HK, Williams R. Annual and lifetime productivity costs and income losses in Persons with Rheumatoid Arthritis. Arthritis and Rheumatism (Suppl). 2003;48:S243.
Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis & Rheumatism. 2003 Oct;48(10):2750-62.
Wolfe F, Burke TA, Pettitt D. Do gastroprotective drugs prevent NSAID toxicity? Reply. JRheumatol. 2003;30(1):203-.
Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. JRheumatol. 2003;30(1):36-40.
Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. JRheumatol. 2003;30(2):369-78.
Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2003;48(6):1530-42.
Wolfe F, Fries JF. Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2003;48(9):2694-5.
Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. JRheumatol. 2003;30(8):1671-2.
Wolfe F, Pincus T, Thompson AK, Doyle J. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis & Rheumatism. 2003;49(1):59-63.
Wolfe F, Michaud K, Stephenson B, Doyle J. Toward a Definition and Method of Assessment of Treatment Failure and Treatment Effectiveness: The Case of Leflunomide versus Methotrexate. JRheumatol. 2003;30(8):1725-32.
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 2002;3(3):170-6.
Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, et al. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology(Oxford). 2002;41(12):1346-56.
Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. JRheumatol. 2002;29(3):467-73.
Wolfe F, Pincus T, Tennant A. HAQ-II: Application of modern item response theory to the design of an improved HAQ questionnaire. AnnRheumDis. 2002;61:190.
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis & Rheumatism. 2002;46(9):2320-9.
Wolfe F. Hypertension among patients with rheumatoid and osteoarthritis participating in the National Data Bank for Rheumatic Diseases. JRheumatol. 2002.
Wolfe F, Flowers N, Burke TA, Arguelles LM, Pettitt D. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. JRheumatol. 2002;29(5):1015-22.
Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate therapy and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-7.
Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. JRheumatol. 2002;29(8):1639-45.
Duryea J, Zaim S, Wolfe F. Neural network based automated algorithm to identify joint locations on hand/wrist radiographs for arthritis assessments. MedPhys. 2002;29(3):403-11.
Wolfe F, Lane NE, Buckland-Wright C. Radiographic Methods in Knee Osteoarthritis: A Further Comparison of Semiflexed (MTP), Schuss-Tunnel, and Weight-Bearing Anteroposterior Views for Joint Space Narrowing and Osteophytes. JRheumatol. 2002;29(12):2597-601.
Wolfe F. The determination and measurement of functional disability in rheumatoid arthritis. Arthritis Res. 2002;4 Suppl 2:S11-S5.
Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. JRheumatol. 2002;29(6):1147-55.
Wolfe F, Lane NE. The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis. JRheumatol. 2002;29(1):139-46.
Wolfe F. The psychometrics of functional status questionnaires: room for improvement. JRheumatol. 2002;29(5):865-8.
Wolfe F, Michaud K. Toward an acceptable definition of DMARD failure and abnormal health status in RA. Arthritis and Rheumatism (Suppl). 2002;46(9):S865.
Choi HK, Michaud K, Wolfe F. Utility measures in rheumatic diseases. Arthritis and Rheumatism (Suppl). 2002;46(9).
Wolfe F, Cush JJ, O’Dell JR, Kavanaugh A, Kremer JM, Lane NE, et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis1330. JRheumatol. 2001;28(6):1423-30.
Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee1214. Arthritis & Rheumatism. 2001;44(7):1587-98.
Wolfe F, Choi HK. Benchmarking and the percentile assessment of RA: adding a new dimension to rheumatic disease measurement. AnnRheumDis. 2001;60(11):994-5.
Wolfe CV. Disability evaluation of fibromyalgia. Phys Med Rehabil Clin N Am. 2001 Aug;12(3):709-18.
Wolfe F, O’Dell JR, Kavanaugh A, Wilske K, Pincus T. Evaluating severity and status in rheumatoid arthritis1328. JRheumatol. 2001;28(6):1453-62.
Wolfe F, Pincus T, O’Dell J. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy. JRheumatol. 2001;28(7):1712-7.
Pincus T, Wolfe F, Strand V, Kavanaugh A, Crawford B, Felson D. Patient questionnaire data discriminate between drug versus placebo as effectively as the ACR20 in a clinical trial of patients with rheumatoid arthritis (RA). Arthritis and Rheumatism (Suppl). 2001;43(9):S288.
Pincus T, Sokka T, Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis & Rheumatism. 2001;44(6):1234-6.
Wolfe F, Strand V. Radiography of rheumatoid arthritis in the time of increasing drug effectiveness795. CurrRheumatolRep. 2001;3(1):46-52.
Wolfe F, Rehman Q, Lane NE, Kremer J. Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment1143. JRheumatol. 2001;28(7):1704-11.
Wolfe F, Pincus T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. JRheumatol. 2001;28(8):1817-24.
Wolfe F, Flowers N, Anderson J, Urbansky K. Tuberculosis rates are not increased in rheumatoid arthritis (RA). Arthritis and Rheumatism (Suppl). 2001;44(9):S105-S-.
Wolfe F, Pincus T, Fries JF. Usefulness of the HAQ in the clinic. AnnRheumDis. 2001;60(8):811.
Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. JRheumatol. 2001;28(5):982-9.
Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis & Rheumatism. 2000;43(12):2751-61.
Pincus T, Wolfe F. An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol. 2000;27(12):2727-30.
Wolfe F, van der Heijde DM, Larsen A. Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale. JRheumatol. 2000;27(9):2090-9.
Wolfe F. For example is not evidence: fibromyalgia and the law. J Rheumatol. 2000 May;27(5):1115-6.
Wolfe F, Kong SX, Watson DJ. Gastrointestinal symptoms and health related quality of life in patients with arthritis. JRheumatol. 2000;27(6):1373-8.
Wolfe F. Management of fibromyalgia. Ann Intern Med. 2000 Jun 20;132(12):1004; author reply 5.
Wolfe F, Skevington SM. Measuring the epidemiology of distress: The rheumatology distress index. JRheumatol. 2000;27(8):2000-9.
Albert DA, Aksentijevich S, Hurst S, Fries JF, Wolfe F. Modeling therapeutic strategies in rheumatoid arthritis: Use of decision analysis and Markov models. JRheumatol. 2000;27(3):644-52.
Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis & Rheumatism. 2000;43(2):378-85.
Wolfe F. Sayin’ “stand and deliver, for you are a bold deceiver”: Faking Fibromyalgia. JRheumatol. 2000;27(11):2534-5. PubMed link
Hawley DJ, Wolfe F, Lue FA, Moldofsky H. Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients. J Rheumatol. 2001 Aug;28(8):1900-9.
Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. JRheumatol. 2000;27(8):1989-99.
Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: A prospective 13 year study of 2131 patients. JRheumatol. 2000;27(7):1668-73.
Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis [see comments]. JRheumatol. 2000;27(3):630-7.
Wolfe F. The importance of gastrointestinal (GI) symptom severity in rheumatoid and osteoarthritis: symptom rates and risk for GI hospitalization. J Rheumatol. 2000;27(7):1661-7.
Wolfe F, Pincus T. The rheumatoid arthritis percentile activity score (PAS): methods and validation. Arthritis and Rheumatism (Suppl). 2000;43(9):S151.
Wolfe F. “Silicone Related Symptoms” Are Common In Patients with Fibromyalgia:No Evidence for A New Disease. JRheumatol. 1999;26(5):1172-5.
Aronoff GM, Markowitz M, Dorto AJ, Ranavaya MI, Talmage JB, Wolfe F, et al. AADEP Position Paper – Fibromyalgia: impairment and disability issues. American Academy of Disability Examining Physicians. 1999;8(3 – Special Pull out section):1-10.
Wolfe F. Critical issues in longitudinal and observational studies: Purpose, short versus long term, selection of study instruments, methods, outcomes, and biases. JRheumatol. 1999;26(2):469-72.
Wolfe F, Pincus T. Current comment – Listening to the patient – A practical guide to self-report questionnaires in clinical care. Arthritis & Rheumatism. 1999;42(9):1797-808.
Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford). 1999;38(4):355-61.
Wolfe F, Hawley DJ, Pincus T. Disease modifying antirheumatic drugs (DMARD) and DMARD combination use by 3604 patients of 303 US rheumatologists. Arthritis and Rheumatism (Suppl). 1999;42:S379.
Ehrich EW, Schnitzer TJ, McIlwain H, Levy R, Wolfe F, Weisman M, et al. Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group491. JRheumatol. 1999;26(11):2438-47.
Wolfe F, Hawley DJ. Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol. 1999 May-Jun;17(3):297-303.
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs [see comments] [published erratum appears in N Engl J Med 1999 Aug 12;341(7):548]. New England Journal of Medicine. 1999;340(24):1888-99.
Wolfe F, Hawley DJ, Anderson JA. Inflammation as measured by the esr predicts cardiovascular mortality across all rheumatic disorders: a 25-year prospective study 0f 5,822 patients. Arthritis and Rheumatism (Suppl). 1999;42(9):S299.
Wolfe EW, Chiu CW. Measuring change across multiple occasions using the Rasch Rating Scale Model. J OutcomeMeas. 1999;3(4):360-81.
Wolfe EW, Chiu CW. Measuring pretest-posttest change with a Rasch Rating Scale Model. J OutcomeMeas. 1999;3(2):134-61.
Kavanaugh AF, Wolfe F, Ward M. New treatments for rheumatoid arthritis: A managed care perspective – Questions and answer session. AmJ ManagCare. 1999;5(14):S866-S9.
Wolfe F, Lassere M, van der HD, Stucki G, Suarez-Almazor M, Pincus T, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology45. JRheumatol. 1999;26(2):484-9.
Wolfe F. Psychological distress and rheumatic disease39. ScandJRheumatol. 1999;28(3):131-6.
Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains. JRheumatol. 1999;26(2):504-7.
Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999;58(9):563-8.
Kavanaugh AF, Wolfe F, Auslander M, Bresloff T, Clark DL, Hillman D, et al. Roundtable II: Cost concerns for rheumatoid arthritis treatment. AmJ ManagCare. 1999;5(14):S880-S8.
Wolfe F, Anderson J. Silicone filled breast implants and the risk of fibromyalgia and rheumatoid arthritis. JRheumatol. 1999;26(9):2025-8.
Wolfe F, Hawley DJ, Pincus T. Standard values for self-report questionnaires: assessments in 20,574 rheumatic disease patients. Arthritis and Rheumatism (Suppl). 1999;42:S75-S.
Buckland-Wright JC, Wolfe F, Ward RJ, Flowers N, Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: A comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. JRheumatol. 1999;26(12):2664-74.
Wolfe F. The burden of rheumatoid arthritis. AmJ ManagCare. 1999;5(14):S852-S9.
Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis & Rheumatism. 1999 Oct;42(10):2220-30.
Hawley DJ, Wolfe F, Pincus T. Use of combination therapy in the routine care of patients with rheumatoid arthritis: Physician and patient surveys. ClinExpRheumatol. 1999;17(6):S78-S82.
Flowers N, Wolfe F. What do rheumatologists do in their practices? Arthritis and Rheumatism (Suppl). 1999;41(9):S337.
Maini RN, Wolfe F. Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritis. Rheumatology(Oxford). 1999;38 Suppl 2:48-9.
Wolfe F. A comparison of IgM rheumatoid factor by nephelometry and latex methods: Clinical and laboratory significance. ArthritCare Res. 1998;11(2):89-93.
Wolfe F, Albert DA, Pincus T. A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis. ArthritCare Res. 1998;11(5):375-81.
Wolfe F, Neumann L, Buskila D. Altered nociception, but not fibromyalgia, after cervical spine injury: Comment on the article by Buskila et al – Reply. Arthritis & Rheumatism. 1998 -32676;41(1):183-4.
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis & Rheumatism. 1998;41(5):778-99.
Wolfe F, Winfield JB. Fibromyalgia Consensus Report: A few more comments. JcrJ ClinRheumatol. 1998;4(3):118-9.
Wolfe F. Fibromyalgia in a grand bio-psycho-social model – Reply. JRheumatol. 1998;25(5):1029-30.
Wolfe F. Inflammatory activity, but not methotrexate or prednisone use predicts non_Hodgkin’s lymphoma in rheumatoid arthritis. Arthritis and Rheumatism (Suppl). 1998;41:S188.
Wolfe F, Hawley DJ, Pincus T. Methotrexate alters the course of rheumatoid arthritis (RA). Increased survival of methotrexate treated RA patients: a 25-years study of 1,842 patients. Arthritis & Rheumatism. 1998;41(9):S188.
Wolfe F, Hawley DJ. Psychosocial factors and the fibromyalgia syndrome. ZRheumatol. 1998;57:88-91.
Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis & Rheumatism. 1998;41(9):1571-82.
Wolfe FA. The causes of fibromyalgia. JcrJ ClinRheumatol. 1998;4(6):299-300.
Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis & Rheumatism. 1998;41(6):1072-82.
Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. JRheumatol. 1998;25(11):2108-17.
Wolfe F, Flowers N, Anderson J. The National Rheumatic Disease Data Bank: case mix and severity characteristics of patients in rheumatological practice. Arthritis and Rheumatism (Suppl). 1998;41(9):S132.
Wolfe F. What use are fibromyalgia control points? Dr. Wolfe replies. JRheumatol. 1998;25(12):2476.
Wolfe F. What use are fibromyalgia control points? JRheumatol. 1998;25(3):546-50.
Prupas HM1, Loose LD, Spindler JS, Dietz AJ Jr, Gum OB, Weisman MH,et al. Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study. Scand J Rheumatol. 1996;25(6):345-51. PubMed link